文献速递眼底病与葡萄膜炎神经眼科

视网膜血管炎的临床结局及缺血性视网膜血管炎预后预测因素

Clinical Outcome of Retinal Vasculitis and Predictors for Prognosis of Ischemic Retinal Vasculitis.
PubMed 文献 · Am J Ophthalmol · 2017-03-02

回顾性队列研究纳入英国伦敦Moorfields眼科医院1169例葡萄膜炎患者,视网膜血管炎见于236眼(缺血性121眼、非缺血性115眼),并与1022眼无视网膜血管炎对照组比较。视网膜血管炎组视力丧失风险显著高于对照组(HR 1.67,95%CI 1.24-2.25,P=.001),黄斑缺血使视力丧失风险增加4.4倍,全身泼尼松龙与视力丧失风险降低相关(HR 0.36,95%CI 0.15-0.82,P=.01)。缺血累及≥2个象限是新血管形成危险因素(HR 2.7,95%CI 1.3-5.5,P=.003)。

要点

  • 视网膜血管炎组视力丧失风险显著高于无血管炎组(HR 1.67,95%CI 1.24-2.25,P=.001)。
  • 黄斑缺血使血管炎眼视力丧失风险增加4.4倍,黄斑水肿风险约为无血管炎组的2倍。
  • 缺血累及≥2个象限与新血管形成风险升高相关(HR 2.7,95%CI 1.3-5.5,P=.003)。

核心结论

  • 视网膜血管炎与视力丧失风险增加相关,主要继发于黄斑缺血,且黄斑水肿风险高于无血管炎眼。
  • 缺血累及≥2个象限是新血管形成的危险因素。

研究设计与样本

  • 回顾性队列研究,复习英国伦敦Moorfields眼科医院1169例葡萄膜炎患者。
  • 视网膜血管炎见于236眼(缺血性121眼、非缺血性115眼),与1022眼无视网膜血管炎对照组比较。
  • 对63眼缺血性血管炎行超广角荧光素眼底血管造影,以缺血指数定量无灌注区面积。

主要发现

  • 视网膜血管炎组视力丧失风险显著高于无血管炎组(HR 1.67,95%CI 1.24-2.25,P=.001)。
  • 视网膜血管炎组黄斑水肿风险为无血管炎组的2倍。
  • 黄斑缺血使血管炎眼视力丧失风险增加4.4倍。
  • 血管炎眼使用全身泼尼松龙与视力丧失风险降低相关(HR 0.36,95%CI 0.15-0.82,P=.01)。
  • 75眼(62.0%)接受激光光凝,其中29眼(38.1%)出现新生血管复发并需追加激光治疗;缺血指数中位数25.8%(四分位距10.2%-46%)。

关键数值与推荐

  • 缺血累及≥2个象限与新血管形成风险升高相关(HR 2.7,95%CI 1.3-5.5,P=.003)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine factors affecting the visual outcome in eyes with retinal vasculitis and the rate of neovascularization relapse in ischemic vasculitis. DESIGN: Retrospective cohort study. METHODS: We reviewed 1169 uveitis patients from Moorfields Eye Hospital, London, UK. Retinal vasculitis was observed in 236 eyes (121 ischemic, 115 nonischemic) that were compared with a control group (1022 eyes) with no retinal vasculitis. Ultra-widefield fluorescein angiography images were obtained in 63 eyes with ischemic vasculitis to quantify area of nonperfusion measured as ischemic index. RESULTS: The risk of vision loss was significantly more in the retinal vasculitis compared with the non-vasculitis group (hazard ratio [HR] 1.67, 95% confidence interval [CI] 1.24-2.25, P = .001). Retinal vasculitis had twice the risk of macular edema compared to the non-vasculitis group. Macular ischemia increased the risk of vision loss in vasculitis eyes by 4.4 times. The use of systemic prednisolone in eyes with vasculitis was associated with a reduced risk of vision loss (HR 0.36, 95% CI 0.15-0.82, P = .01). Laser photocoagulation was administered in 75 eyes (62.0%), out of which 29 (38.1%) had new vessel relapse and required additional laser treatment. The median ischemic index was 25.8% (interquartile range 10.2%-46%). Ischemia involving ≥2 quadrants was associated with increased risk of new vessel formation (HR 2.7, 95% CI 1.3-5.5, P = .003). CONCLUSIONS: Retinal vasculitis is associated with an increased risk of vision loss, mainly secondary to macular ischemia, and has a higher risk of macular edema compared to eyes with no vasculitis. Ischemia involving ≥2 quadrants is a risk factor for new vessel formation.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Sharief L, Lightman S, Blum-Hareuveni T, et al. Clinical Outcome of Retinal Vasculitis and Predictors for Prognosis of Ischemic Retinal Vasculitis. Am J Ophthalmol. 2017. PMID: 28263735. doi:10.1016/j.ajo.2017.02.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。